Contacts list
Competent authorities of countries participating in the WHO certification scheme on the quality of pharmaceutical products moving in international commerce.
The contact details below are provided by the national authorities. Please send notifications about changes to regulatory_networks@who.int.
Afghanistan (Letter of 29 August 1980; revised based on the information available on NRA’s website as of 01 March 2024)
Website: www.afda.gov.af/en
Algeria (Letter of 14 June 1994; revised based on the information available on NRA’s website as of 01 March 2024)
Website: https://anpp.dz/
Angola (Letter of 23 January 1980; Email 15 November 2023)
Website: https://armed.gov.ao
Argentina (Letter of 4 August 1977; Email 10 January 2023)
Website: www.anmat.gob.ar
Armenia (Letter of 12 July 2009; Email 19 October 2023)
Website: www.pharm.am
Australia (Letters of 26 May 1976, 16 January 1989 and 25 January 1996; revised based on the information available on NRA’s website as of 01 March 2024)
Website: www.tga.gov.au
Austria (Letter of 19 February 2010 and 14 October 2014; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Website: www.ages.at
Bahrain (Letter of 6 June 1979; revised based on the information available on NRA’s website as of 17 January 2024)
Website: www.nhra.bh
Bangladesh (Letter of 15 March 1989; Email 26 December 2022)
Website: https://dgda.portal.gov.bd
Barbados (Letter of 3 March 1983; revised based on the information available on NRA’s website as of 17 January 2024)
Website: http://drugservice.gov.bb/
Belarus (Letter of 24 May 2013; revised based on the information available on NRA’s website as of 01 March 2024)
Website: www.rceth.by/en
Belgium (Letters of 12 October 1977, 17 October 1994, 12 September 2000; Email of 3 October 2003; 15 May 2018; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Website: www.famhp.be
Benin (Letter of 24 November 1982; Email of 28 December 2022)
Bhutan (Letter of 11 July 1989 and 18 October 2022)
Website: www.dra.gov.bt
Bolivia (Letter of 18 September 1979; Email of 10 January 2023)
Website: www.agemed.gob.bo
Botswana (Letter of 14 September 1982; E-mail of 7 February 2024)
Website: www.bomra.co.bw
Brazil (Letters of 23 September 1980 and 12 December 2001, revised based on the information available on NRA’s website as of 23 February 2024)
Website: www.gov.br/anvisa/pt-br/english
Brunei Darussalam (Letter of 16 September 1997; revised based on the information available on NRA’s website as of 23 February 2024)
Website: www.moh.gov.bn
Bulgaria (Letters of 2 July 1982 and 13 March 1997; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Website: www.bda.bg
Burkina Faso (Letter of 29 September 1981; revised based on the information available on NRA’s website as of 23 February 2024)
Website: https://anrp.bf
Burundi (Letter of 8 February 1986; revised based on the information available on NRA’s website as of 17 January 2024)
Cabo Verde (Letter of 14 April 1984; Email 19 January 2023)
Website: www.eris.cv
Cambodia (Letter of 31 December 1993, revised based on the information available on NRA’s website as of 23 February 2024)
Website: ddf.moh.gov.kh
Cameroon (Letter of 15 March 1982, revised based on the information available on NRA’s website as of 26 February 2024)
Website: https://dpml.cm/index.php/fr/
Canada (Letters of 23 February 1983, 6 December 1996 and 9 July 1999, revised based on the information available on NRA’s website as of 26 February 2024)
Website: www.canada.ca/en/health-canada
Central African Republic (Letter of 22 July 1980, revised based on the information available on NRA’s website as of 08 March 2024)
Website: www.sante.gouv.cf
Chad (Letters of 6 February 1986, 10 October 1988 and October 1994)
Chile (Letters of 9 July 1979 and 18 August 1980, revised based on the information available on NRA’s website as of 08 March 2024)
Website: www.ispch.gob.cl
China (Letter of 12 July 2018; Email 29 December 2022)
Website: http://english.nmpa.gov.cn
Colombia (Letter of 14 February 2025)
Website: www.dpm-congo.net
Costa Rica (Letters of 23 August 1979 and 5 February 1993, revised based on the information available on NRA’s website as of 26 February 2024)
Website: https://www.ministeriodesalud.go.cr/
Croatia (Letter 11 August 2020; Email 17 February 2023)
Website: www.halmed.hr
Cuba (Letter of 18 June 1997; revised based on the information available on NRA’s website as of 01 March 2024)
Website: www.cecmed.cu
Cyprus (Letter of 3 March 1976; Letter of 21 November 2023)
Website: www.moh.gov.cy/phs
Czech Republic (Letter of 25 March 1991; Email 28 November 2023)
Website: www.sukl.cz, www.sukl.eu
Democratic Republic of the Congo (Letter of 5 April 1998, revised based on the information available on NRA’s website as of 26 February 2024)
Denmark (Letters of 29 November 1977 and 19 October 1994; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Djibouti (Letter of 16 August 1980; Email 10 January 2023)
Dominican Republic (Letter of 16 October 1992)
Ecuador (Letters of 31 October 1985 and 20 January 1993, revised based on the information available on NRA’s website as of 27 February 2024)
Egypt (Letters of 16 November 1976 and 26 July 1977; Email 22 January 2023)
El Salvador (Letters of 19 January 1978 and 13 October 1993; Email 11 January 2023)
Equatorial Guinea (Letter of 28 August 1991)
Estonia (Letter of 27 November 2023)
Eswatini (Swaziland) (Letter of 9 November 1978; Email 02 March 2023)
Ethiopia (letter of 26 May 1979; revised based on the information available on NRA’s website as of 01 March 2024)
European Union (Letters of 8 May, 3 June 1996, 2 August 2001 and 17 July 2014; Email 31 October 2023)
Fiji (Letter of 30 December 1980; revised based on the information available on NRA’s website as of 27 February 2024)
Finland (Letter of 28 June 1977; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
France (Letters of 23 December 1976, 2 February 1984, June 1995, 24 November 1998 and January 2000; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Gabon (Letter of 12 November 1981; revised based on the information available on NRA’s website as of 08 March 2024)
Website: www.amgabon.ga/index.php
Georgia (Letter of 27 November 2018)
Germany (Letters of 23 July 1985, 15 October 1986, 18 August 1993, 24 November 1997, 5 October 2000, March 2007 and December 2009; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Email: office@soziales.bremen.de
Germany (see also below Laender Health Authorities)
Hesse
Mecklenburg-Vorpommern
Ghana (Letters of 3 July 1979 and 17 January 2003; Email 25 January 2023)
Greece (see also: Hellenic Republic; letter of 27 January 1987 and 21 April 2004; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Guatemala (Letters of 25 May 1979 and 2 September 2002; revised based on the information available on NRA’s website as of 27 February 2024)
Guinea (Letter of 12 September 1980; revised based on the information available on NRA’s website as of 27 February 2024)
Guyana (Letter of 21 January 1980; revised based on the information available on NRA’s website as of 27 February 2024)
Haiti (Letter of 30 January 1984; Email 19 January 2023)
Hellenic Republic (see Greece; letter of 27 January 1987 and 21 April 2004)
Honduras (Letters of 9 September 1991 and 15 December 1992)
Hungary (Letters of 8 August 1983 and 22 December 1996; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Iceland (Letter of 6 July 1977; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
India (Letters of 16 May 1978, 10 August 1990 and 24 January 1998)
Indonesia (Letter of 23 June 1983; Letter 10 May 2023)
Jakarta 10560
Iran (Islamic Republic of) (Letters of 31 January 1978 and 29 July 1996; Email 10 March 2024)
Iraq (Telex of 26 February 1983)
Ireland (Letter of March 1985; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Israel (Letters of 9 March 1978, 19 September 1979 and 29 October 1991; revised based on the NRA’s website as of 07 March 2024)
Italy (Letter of 17 March 1976; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Ivory-Coast (Letter of 24 June 1986)
Jamaica (Letter of 12 August 1980; Email 09 March 2023)
Japan (letters of 21 October 1976 and 19 December 1997; E-mail 8 February 2024)
Jordan (letter of 16 July 1977 and 2 February 2001; revised based on the information available on the NRA’s website as of 27 February.2024)
Kenya (letter of 25 January 1985; E-mail 30 January 2024)
Korea, Republic of (letter of 28 June 1977, fax of 10 October 2003 and email of 22 December 2017) Animal and Plant Quarantine Agency (APQA)
Kuwait (letter received 12 January 1983 and 25 October 1994)
Lao People's Democratic Republic (Letter of 17 August 1994; Email 11 January 2023)
Latvia (letter of 11 September 2017)
Lesotho (letter of 16 October 1986; revised based on the information available on the NRA’s website as of 07 March 2024)
Liberia (letter of 20 July 1978; revised based on the information available on the NRA’s website as of 27 February 2024)
Libya (Letter of 28 December 1981; Email 12 January 2023)
Luxembourg (letter of 12 March 1986; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Madagascar (letter of 29 August 1980)
Malawi (letter of 13 July 1982; revised based on the information available on the NRA’s website as of 27 February 2024)
Malaysia (letters of 16 November 1982, 9 June 1993 and 26 December 1996; revised based on the information available on the NRA’s website as of 27 February 2024)
Maldives (letter of 12 September 1982; revised based on the information available on the NRA’s website as of 27 February 2024)
Mali (letter of 4 November 1981)
Malta (letter of 27 August 1986 and 24 October 1994; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Mauritania (letter of 2 June 1979; revised based on the information available on the NRA’s website as of 28 February 2024)
Mauritius (letter of 1 August 1977; revised based on the information available on the NRA’s website as of 08 March 2024)
Mexico (letters of 9 July 1982, 18 October 1988 and 11 January 1993; revised based on the information available on the NRA’s website as of 28 February 2024)
Mongolia (letter of 14 July 1994)
Morocco (letters of 1 September 1988 and 16 September 1997)
Mozambique (letter of 4 September 1979; Email 16 February 2024)
Myanmar (letter of 11 September 1979; revised based on the information available on the NRA’s website as of 28 February 2024)
Namibia (letter of 15 January 1992 and 18 October 1994; revised based on the information available on the NRA’s website as of 28 February 2024)
Nepal (Letter of 11 March 1984; Email 12 February 2023)
Netherlands (letters of 1 August 1983 and 1 December 1995; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
New Zealand (letters of 18 December 1975, 1 June 1992 and 24 October 1994; revised based on the information available on NRA’s website as of 17 January 2024)
Nicaragua (letters of 20 March 1984 and 10 December 1992)
Nigeria (letter of 5 March 1980; Email 29 January 2024)
Norway (letter of 9 April 1976; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Norwegian Medical Products Agency
Oman (Letters of 9 March 1982, 10 December 1995 and 8 October 1997; Email 22 February 2023)
Pakistan (Letter of 5 May 1979; Email 03 January 2023)
Panama (letter of 29 August 1979)
Papua New Guinea (letter of 1 September 1982; revised based on the information available on NRA’s website as of 28 February 2024)
Paraguay (letter of 30 July 2019; revised based on the information available on NRA’s website as of 28 February 2024)
Peru (letters of 7 October 1980, 24 October 1994 and 18 September 1997; revised based on the information available on NRA’s website as of 28 February 2024)
Philippines (Letters of 3 August 1988 and 9 November 1994; Email 11 January 2023)
Poland (letters of 16 October 1976 and 21 August 1995; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Portugal (letters of 13 February 1976, 28 November 1989, 6 September 1994 and 22 July 1998; revised based on the information available on website of the European Medicines Agency as of 22.02.2024)
Qatar (Letter of 8 June 1982; Email 23 October 2023)
Romania (letters of 29 August 1977 and 12 August 2002; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Russian Federation (letter of 12 March 1999)
Rwanda (letter of 6 June 1979; revised based on the information available on NRA’s website as of 08 March 2024)
Saint Lucia (letter of 21 December 1981)
Sao Tome and Principe (letter of 16 May 1979)
Saudi Arabia (letters of 8 July 1982 and 20 January 1989; revised based on the information available on NRA’s website as of 08 March 2024)
Senegal (letter of 29 August 1977)
Seychelles (letter of 15 September 1981; revised based on the information available on NRA’s website as of 28 February 2024)
Sierra Leone (letter of 26 July 1982; revised based on the information available on NRA’s website as of 08 March.2024)
Singapore (letter of 18 April 1994 and email of 18 January 2022)
Slovak Republic (letters of 25 March 1991 and 2 March 1998; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Slovenia (e-mail from 25 April 2012; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Solomon Islands (memorandum of 6 February 1986; revised based on the information available on NRA’s website as of 08 March.2024)
Somalia (Letter of 13 June 1982; Email 08 January 2023)
South Africa (letter of 28 April 1981; Email 29 January 2024)
Spain (letters of 29 June 1977, 15 July 1983 and 21 April 1986 and 2 March 2000; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Sri Lanka (letter of 16 June 1980; revised based on the information available on NRA’s website as of 08 March 2024)
Sudan (letter of 6 April 1981; revised based on the information available on NRA’s website as of 28 February 2024)
Suriname (letter of 11 December 1986; revised based on the information available on NRA’s website as of 28 February 2024)
Swaziland see Eswatini
Sweden (letter of 1 April 1976; revised based on the information available on website of the European Medicines Agency as of 22 February 2024)
Switzerland (letters of 8 July 1980 and 1 January 2002)
Syrian Arab Republic (letter of 12 November 1975; Email 02 February 2023)
Tanzania (United Republic of) (letter of 27 June 1978; email 6 February 2024)
Thailand (letter of 30 December 1977; revised based on the information available on NRA’s website as of 08 March 2024)
Togo (letter of 4 July 1983)
Trinidad and Tobago (letter of 7 November 1984; revised based on the information available on NRA’s website as of 28 February 2024)
Tunisia (Letter of 8 February 1978; Email 27 October 2023)
Türkiye (letter of 24 September 2004; Email 29 January 2024)
Turkmenistan (letter of 19 January 2017)
Ukraine (letter of 7 July 2012; revised based on the information available on NRA’s website as of 08 March 2024 )
United Arab Emirates (letter of 21 June 1977; revised based on the information available on NRA’s website as of 08 March 2024)
United Kingdom of Great Britain and Northern Ireland (the) (letter of 13 April 1976; Email 29 January 2024)
United Nations Interim Administration Mission in Kosovo (letters of 27 June 2000 and 15 December 2000)
Kosovo Drug Regulatory Authority (KDRA), Department of Health and Social Welfare
United States of America (letters of 5 April 1976, 9 September 1990 and 17 July 2012)
Vanuatu (letter of 26 September 1983; revised based on the information available on NRA’s website as of 08 March 2024)
Venezuela (Bolivarian Republic of) (letter of 5 August 1985; revised based on the information available on NRA’s website as of 08 March 2024)
Yemen (Letter of 9 June 1982; Email 19 January 2023)
Zambia (letter of 31 May 1979; revised based on the information available on NRA’s website as of 08 March 2024)
Zimbabwe (letter of 28 September 1982; email of 29 February 2024)